Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

LUMI-PCR: an Illumina platform ligation-mediated PCR protocol for integration site cloning, provides molecular quantitation of integration sites.

Dawes JC, Webster P, Iadarola B, Garcia-Diaz C, Dore M, Bolt BJ, Dewchand H, Dharmalingam G, McLatchie AP, Kaczor J, Caceres JJ, Paccanaro A, Game L, Parrinello S, Uren AG.

Mob DNA. 2020 Feb 4;11:7. doi: 10.1186/s13100-020-0201-4. eCollection 2020.

2.

High serum substance P levels and mortality after malignant middle cerebral artery infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

J Crit Care. 2020 Jan 20;57:1-4. doi: 10.1016/j.jcrc.2020.01.022. [Epub ahead of print]

PMID:
31991332
3.

Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients.

Lorente L, Martín MM, Abreu-González P, Ramos L, Cáceres JJ, Argueso M, Solé-Violán J, Jiménez A, García-Marín V.

BMC Res Notes. 2019 Dec 3;12(1):789. doi: 10.1186/s13104-019-4828-5.

4.

Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Nov 28;9(12). pii: E346. doi: 10.3390/brainsci9120346.

5.

High Serum Tissue Inhibitor of Matrix Metalloproteinase-1 Levels and Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A.

World Neurosurg. 2020 Feb;134:e476-e480. doi: 10.1016/j.wneu.2019.10.106. Epub 2019 Oct 25.

PMID:
31669537
6.

High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 10;9(10). pii: E269. doi: 10.3390/brainsci9100269.

7.

Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.

Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

BMC Neurol. 2019 Oct 17;19(1):238. doi: 10.1186/s12883-019-1479-z.

8.

High Serum DNA and RNA Oxidative Damage in Non-surviving Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Oct 9. doi: 10.1007/s12028-019-00864-8. [Epub ahead of print]

PMID:
31598840
9.

The Serum Melatonin Levels and Mortality of Patients with Spontaneous Intracerebral Hemorrhage.

Lorente L, Martín MM, Abreu-González P, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Brain Sci. 2019 Oct 1;9(10). pii: E263. doi: 10.3390/brainsci9100263.

10.

High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.

Lorente L, Martín MM, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Dec;132:e630-e636. doi: 10.1016/j.wneu.2019.08.060. Epub 2019 Aug 21.

PMID:
31442656
11.

Persistently High Serum Substance P Levels and Early Mortality in Patients with Severe Traumatic Brain Injury.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Argueso M, Ramos L, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

World Neurosurg. 2019 Dec;132:e613-e617. doi: 10.1016/j.wneu.2019.08.064. Epub 2019 Aug 20.

PMID:
31442647
12.

Association Between DNA and RNA Oxidative Damage and Mortality of Patients with Traumatic Brain Injury.

Lorente L, Martín MM, González-Rivero AF, Pérez-Cejas A, Abreu-González P, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Alvarez-Castillo A, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Aug 5. doi: 10.1007/s12028-019-00800-w. [Epub ahead of print]

PMID:
31385181
13.

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, González-Rivero AF, Orbe J, Rodríguez JA, Páramo JA.

BMC Neurol. 2019 Jul 18;19(1):167. doi: 10.1186/s12883-019-1401-8.

14.

Disease gene prediction for molecularly uncharacterized diseases.

Cáceres JJ, Paccanaro A.

PLoS Comput Biol. 2019 Jul 5;15(7):e1007078. doi: 10.1371/journal.pcbi.1007078. eCollection 2019 Jul.

15.

Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.

Lorente L, Martín MM, Pérez-Cejas A, González-Rivero AF, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

Neurocrit Care. 2019 Dec;31(3):486-493. doi: 10.1007/s12028-019-00739-y.

PMID:
31115825
16.

Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.

Lorente L, Martín MM, González-Rivero AF, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, García-Marín V.

World Neurosurg. 2019 Jun;126:e1537-e1541. doi: 10.1016/j.wneu.2019.03.179. Epub 2019 Mar 27.

PMID:
30926559
17.

Author Correction: Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates.

Webster P, Dawes JC, Dewchand H, Takacs K, Iadarola B, Bolt BJ, Caceres JJ, Kaczor J, Dharmalingam G, Dore M, Game L, Adejumo T, Elliott J, Naresh K, Karimi M, Rekopoulou K, Tan G, Paccanaro A, Uren AG.

Nat Commun. 2019 Mar 6;10(1):1167. doi: 10.1038/s41467-019-09109-w.

18.

Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients.

Lorente L, Martín MM, Ramos L, Argueso M, Cáceres JJ, Solé-Violán J, Jiménez A, Borreguero-León JM, González-Rivero AF, Orbe J, Rodríguez JA, Páramo JA.

J Crit Care. 2019 Jun;51:117-121. doi: 10.1016/j.jcrc.2019.02.014. Epub 2019 Feb 19.

PMID:
30802757
19.

Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates.

Webster P, Dawes JC, Dewchand H, Takacs K, Iadarola B, Bolt BJ, Caceres JJ, Kaczor J, Dharmalingam G, Dore M, Game L, Adejumo T, Elliott J, Naresh K, Karimi M, Rekopoulou K, Tan G, Paccanaro A, Uren AG.

Nat Commun. 2018 Jul 9;9(1):2649. doi: 10.1038/s41467-018-05069-9. Erratum in: Nat Commun. 2019 Mar 6;10(1):1167.

20.

Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction.

Lorente L, Martín MM, Abreu-González P, Pérez-Cejas A, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.

J Int Med Res. 2018 Aug;46(8):3268-3277. doi: 10.1177/0300060518775008. Epub 2018 May 30.

Supplemental Content

Loading ...
Support Center